In 2014, Finland's pharma market saw steady development

Last year, the pharmacy and hospital sectors of the Finnish pharmaceutical market grew relatively steadily, at about 5%, according to the country’s research-based drug industry association PIF.

The growth of the pharmacy market is explained by the advanced pharmacotherapies that allow more patients with severe diseases to stay and be cared for at home, instead of the expensive hospital care. The 5% cut of the prices of reimbursable original medicines, implemented in 2013, also boosted the growth of the pharmacy market by affecting the calculatory growth figures in 2014.

Measured in wholesale prices, the overall value of the Finnish pharmaceutical market was 2.2 billion euros ($2.5 billion) in 2014.